Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global S-Epichlorohydrin Market by Type (98%-98.9%, 99%-99.8%, Greater than or equal to99.9%, Other), By Application (L-carnitine, Atrovastatine, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global S-Epichlorohydrin Market by Type (98%-98.9%, 99%-99.8%, Greater than or equal to99.9%, Other), By Application (L-carnitine, Atrovastatine, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 143463 3300 Chemical & Material 377 242 Pages 4.8 (38)
                                          

Market Overview:


The global S-Epichlorohydrin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for L-carnitine and atrovastatine. North America is expected to dominate the market during the forecast period, followed by Europe and Asia Pacific.


Global S-Epichlorohydrin Industry Outlook


Product Definition:


S-Epichlorohydrin is an organic compound with the formula ClCH2CH2O. It is a colorless liquid that is soluble in water and alcohol. It is used to make epoxy resins, which are adhesives and coatings.


98%-98.9%:


98%-98.9% is a key range of epichlorohydrin, which is used as an intermediate in the production of many chemicals such as solvents, adhesives and coatings removers and surfactants.


99%-99.8%:


99%-99.8% is a high purity grade of epichlorohydrin which has 99.8% of the chemical composition and less than 1% impurities, it is used as an intermediate in manufacturing scopolamine base for motion sickness drugs and other pharmaceutical products.


Application Insights:


L-carnitine was the most dominant application segment in terms of volume and revenue in 2017. The product is used as an ingredient for manufacturing dietary supplements and pharmaceuticals. It has a significant demand from the healthcare industry due to its ability to help maintain lean muscle mass, improve performance, enhance endurance, decrease fatigue and promote weight management.


The atrovastatin segment is expected to witness lucrative growth over the forecast period owing to its rising use as an active pharmaceutical ingredient (API) for manufacturing several cholesterol-lowering drugs such as Zocor, Atroventseaside 5/10 mg & 10/20 mg tablets by Pfizer Inc., Pravachol by Bayer HealthCare LLC., Lescol by Merck KGaA Darmstadt GmbH & Co.


Regional Analysis:


Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The growth of this region can be attributed to increasing product demand from key application sectors including pharmaceutical, agrochemical, nutraceuticals, cosmetics and food additives. China is one of the largest producers as well as consumers of these chemicals globally. It produced around 9 million tons in 2016 and consumed nearly 7 million tons during the same year resulting in a net export quantity for that year.


The country has been witnessing strong economic growth on account of rapid industrialization along with urbanization leading to an increase in disposable income per capita which eventually drives consumer spending on various goods including food supplements & additives for domestic use or export across other countries such as India, Japan etc., thus driving industry expansion over past few years.- High population coupled with high demand from end-use industries such as cosmetics & personal care products due to growing awareness regarding appearance enhancement among millennials will drive regional market growth.


Growth Factors:


  • Increasing demand from end-use industries such as pharmaceuticals, agrochemicals, and water treatment is expected to drive the S-Epichlorohydrin market growth.
  • Growing awareness about the benefits of using S-Epichlorohydrin in various applications is projected to boost the market growth.
  • Rising investments by key players for expanding their production capacities is likely to propel the market growth in near future.
  • Stringent environmental regulations regarding VOC emissions are anticipated to create new opportunities for S-Epichlorohydrin manufacturers over the forecast period .

Scope Of The Report

Report Attributes

Report Details

Report Title

S-Epichlorohydrin Market Research Report

By Type

98%-98.9%, 99%-99.8%, Greater than or equal to99.9%, Other

By Application

L-carnitine, Atrovastatine, Other

By Companies

Jinma Chem, Huayang Pharm, Gold Jyouki Tech, Yetop Fine Chem, Kely Biopharm, Demchem, Qingxin Chem, Huitao Chem

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

242

Number of Tables & Figures

170

Customization Available

Yes, the report can be customized as per your need.


Global S-Epichlorohydrin Market Report Segments:

The global S-Epichlorohydrin market is segmented on the basis of:

Types

98%-98.9%, 99%-99.8%, Greater than or equal to99.9%, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

L-carnitine, Atrovastatine, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Jinma Chem
  2. Huayang Pharm
  3. Gold Jyouki Tech
  4. Yetop Fine Chem
  5. Kely Biopharm
  6. Demchem
  7. Qingxin Chem
  8. Huitao Chem

Global S-Epichlorohydrin Market Overview


Highlights of The S-Epichlorohydrin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 98%-98.9%
    2. 99%-99.8%
    3. Greater than or equal to99.9%
    4. Other
  1. By Application:

    1. L-carnitine
    2. Atrovastatine
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the S-Epichlorohydrin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global S-Epichlorohydrin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


S-Epichlorohydrin is a chlorohydrin with the epoxide group replaced by an S atom.

Some of the major companies in the s-epichlorohydrin market are Jinma Chem, Huayang Pharm, Gold Jyouki Tech, Yetop Fine Chem, Kely Biopharm, Demchem, Qingxin Chem, Huitao Chem.

The s-epichlorohydrin market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. S-Epichlorohydrin Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. S-Epichlorohydrin Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. S-Epichlorohydrin Market - Supply Chain
   4.5. Global S-Epichlorohydrin Market Forecast
      4.5.1. S-Epichlorohydrin Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. S-Epichlorohydrin Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. S-Epichlorohydrin Market Absolute $ Opportunity

5. Global S-Epichlorohydrin Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. S-Epichlorohydrin Market Size and Volume Forecast by Type
      5.3.1. 98%-98.9%
      5.3.2. 99%-99.8%
      5.3.3. Greater than or equal to99.9%
      5.3.4. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global S-Epichlorohydrin Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. S-Epichlorohydrin Market Size and Volume Forecast by Application
      6.3.1. L-carnitine
      6.3.2. Atrovastatine
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global S-Epichlorohydrin Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. S-Epichlorohydrin Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global S-Epichlorohydrin Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. S-Epichlorohydrin Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global S-Epichlorohydrin Demand Share Forecast, 2019-2026

9. North America S-Epichlorohydrin Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America S-Epichlorohydrin Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America S-Epichlorohydrin Market Size and Volume Forecast by Application
      9.4.1. L-carnitine
      9.4.2. Atrovastatine
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America S-Epichlorohydrin Market Size and Volume Forecast by Type
      9.7.1. 98%-98.9%
      9.7.2. 99%-99.8%
      9.7.3. Greater than or equal to99.9%
      9.7.4. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America S-Epichlorohydrin Demand Share Forecast, 2019-2026

10. Latin America S-Epichlorohydrin Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America S-Epichlorohydrin Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America S-Epichlorohydrin Market Size and Volume Forecast by Application
      10.4.1. L-carnitine
      10.4.2. Atrovastatine
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America S-Epichlorohydrin Market Size and Volume Forecast by Type
      10.7.1. 98%-98.9%
      10.7.2. 99%-99.8%
      10.7.3. Greater than or equal to99.9%
      10.7.4. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America S-Epichlorohydrin Demand Share Forecast, 2019-2026

11. Europe S-Epichlorohydrin Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe S-Epichlorohydrin Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe S-Epichlorohydrin Market Size and Volume Forecast by Application
      11.4.1. L-carnitine
      11.4.2. Atrovastatine
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe S-Epichlorohydrin Market Size and Volume Forecast by Type
      11.7.1. 98%-98.9%
      11.7.2. 99%-99.8%
      11.7.3. Greater than or equal to99.9%
      11.7.4. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projecions by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe S-Epichlorohydrin Demand Share, 2019-2026

12. Asia Pacific S-Epichlorohydrin Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific S-Epichlorohydrin Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific S-Epichlorohydrin Market Size and Volume Forecast by Application
      12.4.1. L-carnitine
      12.4.2. Atrovastatine
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific S-Epichlorohydrin Market Size and Volume Forecast by Type
      12.7.1. 98%-98.9%
      12.7.2. 99%-99.8%
      12.7.3. Greater than or equal to99.9%
      12.7.4. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific S-Epichlorohydrin Demand Share, 2019-2026

13. Middle East & Africa S-Epichlorohydrin Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa S-Epichlorohydrin Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa S-Epichlorohydrin Market Size and Volume Forecast by Application
      13.4.1. L-carnitine
      13.4.2. Atrovastatine
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa S-Epichlorohydrin Market Size and Volume Forecast by Type
      13.7.1. 98%-98.9%
      13.7.2. 99%-99.8%
      13.7.3. Greater than or equal to99.9%
      13.7.4. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa S-Epichlorohydrin Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global S-Epichlorohydrin Market: Market Share Analysis
   14.2. S-Epichlorohydrin Distributors and Customers
   14.3. S-Epichlorohydrin Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Jinma Chem
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Huayang Pharm
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Gold Jyouki Tech
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Yetop Fine Chem
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Kely Biopharm
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Demchem
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Qingxin Chem
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Huitao Chem
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us